|
|
|
MIRA INFORM REPORT
|
Report No. : |
486642 |
|
Report Date : |
18.01.2018 |
IDENTIFICATION DETAILS
|
Name : |
DPB ANTIBIOTICS |
|
|
|
|
Registered
Office : |
507, 508, 509, Exim Link Opposite Indira Container Yard, Near Nahur
Railway Station Nahur (West), Mulund Goregaon Link Road, Bhandup (West),
Mumbai – 400078, Maharashtra |
|
Tel. No.: |
91-22-25628300 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on)
: |
31.03.2016 |
|
|
|
|
Year of
Establishment : |
2004 |
|
|
|
|
Capital
Investment : |
INR 115.357 Million |
|
|
|
|
IEC No.: |
0304009865 |
|
|
|
|
GST No.: |
27AAKFM1274G1Z8 |
|
|
|
|
TIN No.: |
27850044440 |
|
|
|
|
TAN No.: [Tax Deduction & Collection
Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAKFM1274G |
|
|
|
|
Legal Form : |
Partnership Concern with an Unlimited Liability of the Partners |
|
|
|
|
Line of Business
: |
Exporter, Importer, Trader, Dealer and Distributor of Active
Pharmaceutical Ingredients (API).
(Confirmed by Management) |
|
|
|
|
No. of Employees
: |
42 (Approximately) |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January
2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Maximum Credit Limit : |
USD 329500 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
DPB Antibiotics is a trader, dealer and distributor of Active Pharma Ingredients. The concern was started in the year 2004 and is based in Mumbai, Maharashtra. It is an established partnership concern having satisfactory track record. Mr. Bhavin Ajmera (Partner) provided information and also claimed that concern has achieved healthy revenue of INR 190.000 million during FY2017 (revenue figure could not be verified) As per available audited financials of 2016, the concern has reported decent sales turnover along with satisfactory profit margin. Rating also takes into consideration concern established track record, promoter’s extensive experience in the pharmaceuticals sector and decent financial profile. Trade relations are fair. Business is active. Payment terms are reported to be usually correct and as per commitments. The concern can be considered for business dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
Long Term Rating=BB+ |
|
Rating Explanation |
Moderate risk of default |
|
Date |
27.02.2017 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 18.01.2018.
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION PARTED BY
|
Name : |
Mr. Bhavin Ajmera |
|
Designation : |
Partner |
|
Contact No.: |
91-22-25628300 |
|
Date : |
16.01.2018 |
LOCATIONS
|
Registered Office : |
507, 508, 509, Exim Link Opposite Indira Container Yard, Near Nahur Railway
Station Nahur (West), Mulund-Goregaon Link Road, Bhandup (West), Mumbai –
400078, Maharashtra, India |
|
Tel. No.: |
91-22-25628300/ 61045300 |
|
Fax No.: |
91-22-25665860 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
900 Sq. ft. |
|
Location : |
Owned |
|
Locality : |
Commercial |
|
|
|
|
Warehouse 1 : |
No. 12, Ganesh Compound, House No. 1027/ 12 Inside Krishna Compound,
B/h Rahul Kanta and Vtrans Kurla Village Bhiwandi, Thane-421302, Maharashtra,
India |
|
Location : |
Owned |
|
|
|
|
Warehouse 2 : |
No. 19, Jaishreeram Complex, House No. 1079, Survey No. 147, Opposite
JK Petrol Pump, Kurla Village Bhiwandi, Thane-421302, Maharashtra, India |
|
|
|
|
Corporate Office : |
309 to 3014, 3rd Floor, Exim Link, Opposite Indira Container
Yard, Near Nahur Railway Station Nahur (West), Mulund Goregaon Link Road,
Bhandup (West), Mumbai – 400078, Maharashtra, India |
|
Location : |
Owned |
|
Locality : |
Commercial |
PARTNERS
|
Name : |
Mr. Bhavin Ajmera |
|
Designation : |
Partner |
|
PAN No.: |
AGWPA3930H |
|
|
|
|
Name : |
Mr. Devang Ajmera |
|
Designation : |
Partner |
|
|
|
|
Name : |
Mr. Piyush Ajmera |
|
Designation : |
Partner |
|
PAN No.: |
ABQPA3127R |
BUSINESS DETAILS
|
Line of Business : |
Exporter, Importer, Trader, Dealer and Distributor of Active
Pharmaceutical Ingredients (API).
(Confirmed by Management) |
|
|
|
|
Products/ Services : |
·
Penicillin ·
Microlides ·
Quinolones ·
Oncology ·
Hormond ·
Antiretroviral ·
Cephalosporins ·
Carbapenam ·
Anti-ulcer ·
Antihypertensive ·
Steroids ·
Cardiac |
|
|
|
|
Brand Names : |
Not Available |
|
|
|
|
Agencies Held : |
Not Available |
|
|
|
|
Exports : |
|
|
Products : |
Active Pharmaceutical Ingredients (API) |
|
Countries : |
· South America · South Africa · Nigeria · Kenya · Gulf Countries |
|
|
|
|
Imports : |
|
|
Products : |
Active Pharmaceutical Ingredients (API) |
|
Countries : |
China |
|
|
|
|
Terms : |
|
|
Selling : |
Cash, L/C, Cheque and Credit (30 days and 60 days) |
|
|
|
|
Purchasing : |
Cash, L/C, Cheque and Credit (30 days and 60 days) |
GENERAL INFORMATION
|
Suppliers : |
· Spansules Pharmatech Limited · Shanghai Modern Pharmaceutical Company Limited · Hebei Huaxu Pharmaceutical Company Limited · Arihantam Lifecare Limited · Abhilasha Pharma Private Limited · Virupaksha Orgenics Limited · Zhejiang Hisun Pharmaceutical Company Limited · Zhejiang Zhenyuan Pharmaceutical Company Limited ·
Changshu Fushilai Medicine And Chemical
Company |
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Customers : |
Wholesalers, Retailers and End Users
·
Pfizer Limited ·
Nirma Limited ·
Anuh Pharma Limited ·
Ajanta Pharma Limited ·
Parabolic Drugs Limited ·
Piramal Healthcare Limited ·
Divis Laboratories Limited ·
Medly Pharmaceutical Limited ·
Abbott Laboratories Private Limited ·
Cadila Pharmaceutical Limited ·
Lupin Limited ·
Msn Labs Limited ·
Wockhardt Limited ·
Hetero Drugs Limited ·
Glenmark Pharma Limited ·
Aurobindo Pharma Limited ·
Alkem Laboratories Limited ·
Emcure Pharmaceutical Limited ·
Covlent Laboratories Limited ·
Aristo Pharmaceutical Private Limited |
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
No. of Employees : |
42 (Approximately) |
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Auditors : |
|
|
Name : |
Jayshree Jain and Company Chartered Accountants |
|
Address : |
501, Mahavir Symphony, Near Punjab National Bank, Zaver Road, Mulund
(West), Mumbai-400080, Maharashtra, India |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Sister Concerns : |
· Park Antibiotics Private Limited · DBS Foods and Flavours · SR Biochem |
CAPITAL STRUCTURE
AS ON 31.03.2016
MR. PIYUSH AJMERA
|
PARTICULARS |
AMOUNT |
PARTICULARS |
AMOUNT |
|
Drawings |
2.064 |
Balance B/F |
33.567 |
|
Income Tax (SA
Tax-Firm) |
2.079 |
Partners’ Remuneration |
1.800 |
|
Income Tax (SA
Tax-Self) |
0.403 |
Share of Net Profit |
11.858 |
|
Profession Tax |
0.002 |
Introduction |
3.350 |
|
Balance C/F |
46.028 |
Dividend Saraswat |
0.001 |
|
|
|
|
|
|
Total |
50.576 |
Total |
50.576 |
MR. DEVANG AJMERA
|
PARTICULARS |
AMOUNT |
PARTICULARS |
AMOUNT |
|
Drawings |
6.674 |
Balance B/F |
21.413 |
|
Income Tax (SA
Tax-Firm) |
2.079 |
Partners’ Remuneration |
2.400 |
|
Income Tax (SA
Tax-Self) |
0.498 |
Share of Net Profit |
11.855 |
|
Profession Tax |
0.002 |
Introduction |
4.050 |
|
Balance C/F |
30.466 |
Dividend Saraswat |
0.001 |
|
|
|
|
|
|
Total |
39.719 |
Total |
39.719 |
MR. BHAVIN AJMERA
|
PARTICULARS |
AMOUNT |
PARTICULARS |
AMOUNT |
|
Drawings |
8.703 |
Balance B/F |
29.362 |
|
Income Tax (SA
Tax-Firm) |
2.079 |
Partners’ Remuneration |
2.400 |
|
Income Tax (SA
Tax-Self) |
0.519 |
Share of Net Profit |
11.854 |
|
Profession Tax |
0.003 |
Introduction |
6.550 |
|
Balance C/F |
38.863 |
Dividend Saraswat |
0.001 |
|
|
|
|
|
|
Total |
50.167 |
Total |
50.167 |
FINANCIAL DATA
[all figures are in
INR Million]
|
PARTICULARS |
|
|
31.03.2017 |
|
Sales Turnover (Approximately) |
|
|
190.000 |
|
|
|
|
|
The above information has been parted by Mr. Bhavin Ajmera (Partner).
Note : Sole Proprietary and Partnership concerns are exempted
from filing their financials with the Government Authorities or Registry.
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
|
31.03.2016 |
31.03.2015 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Partner Capital Account |
|
115.357 |
84.341 |
|
|
2] Reserves & Surplus |
|
0.000 |
0.000 |
|
|
NETWORTH |
|
115.357 |
84.341 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
56.381 |
27.134 |
|
|
2] Unsecured Loans |
|
63.332 |
70.073 |
|
|
TOTAL BORROWING |
|
119.713 |
97.207 |
|
|
DEFERRED TAX LIABILITIES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
235.070 |
181.548 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
4.488 |
4.728 |
|
|
Capital work-in-progress |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
19.018 |
9.909 |
|
|
DEFERREX TAX ASSETS |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
149.714
|
88.327 |
|
|
Sundry Debtors |
|
494.437
|
388.815 |
|
|
Cash & Bank Balances |
|
8.455
|
1.484 |
|
|
Other Current Assets |
|
0.000
|
0.000 |
|
|
Loans & Advances |
|
5.607
|
6.127 |
|
Total
Current Assets |
|
658.213
|
484.753
|
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
445.403
|
317.287 |
|
|
Other Current Liabilities |
|
0.000
|
0.000 |
|
|
Provisions |
|
1.246
|
0.555 |
|
Total
Current Liabilities |
|
446.649
|
317.842
|
|
|
Net Current Assets |
|
211.564
|
166.911 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
235.070 |
181.548 |
|
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales |
|
1538.358 |
1299.327 |
|
|
|
Other Income |
|
18.745 |
8.825 |
|
|
|
TOTAL |
|
1557.103 |
1308.152 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Goods Sold |
|
1322.959 |
1175.845 |
|
|
|
Custom and Excies Duty |
|
124.278 |
62.262 |
|
|
|
Shipping Agent’s Charges (Import) |
|
1.485 |
0.861 |
|
|
|
Excise Duty |
|
0.030 |
0.000 |
|
|
|
Clearing and Forwarding Exp. |
|
5.598 |
2.480 |
|
|
|
Transportation and Octroi (Inwards) |
|
1.029 |
1.127 |
|
|
|
Purchase-Rate Difference |
|
0.000 |
0.019 |
|
|
|
Exchange-Rate Difference (Import) |
|
12.376 |
4.419 |
|
|
|
Salary and Wages |
|
3.773 |
4.857 |
|
|
|
Auditors Remuneration |
|
0.195 |
0.130 |
|
|
|
A/c Supervision Charges |
|
0.116 |
0.048 |
|
|
|
Legal and Professional Fees |
|
1.127 |
2.053 |
|
|
|
Exchange Rate Diff (Export) |
|
0.255 |
0.335 |
|
|
|
Clearing and Forwarding Charges (Exports) |
|
1.017 |
1.204 |
|
|
|
Brokerage and Commission |
|
4.151 |
3.915 |
|
|
|
Godown Insurance |
|
0.486 |
0.478 |
|
|
|
Transit Insurance |
|
0.612 |
0.459 |
|
|
|
General Insurance |
|
0.030 |
0.017 |
|
|
|
Loading and Hamali Charges |
|
1.000 |
1.103 |
|
|
|
Packing and Forwarding |
|
0.298 |
0.118 |
|
|
|
Telephone and Mobile Charges |
|
0.630 |
0.634 |
|
|
|
Transportation Charges |
|
1.882 |
1.173 |
|
|
|
Advertisement Expenses |
|
0.086 |
0.049 |
|
|
|
Office Rent |
|
0.274 |
0.066 |
|
|
|
Godown Rent |
|
0.152 |
0.000 |
|
|
|
Computer Service Charges |
|
0.188 |
0.081 |
|
|
|
Courier Charges |
|
0.509 |
0.456 |
|
|
|
Repairs and Maintenance |
|
0.382 |
0.534 |
|
|
|
Printing and Stationary |
|
0.542 |
0.968 |
|
|
|
Parkings, Tolls and Fuel |
|
0.347 |
0.279 |
|
|
|
Partners Remuneration |
|
6.600 |
2.900 |
|
|
|
Other Expenses |
|
11.578 |
7.585 |
|
|
|
TOTAL |
|
1503.985 |
1276.455 |
|
|
|
|
|
|
|
|
|
PROFIT BEFORE INTEREST
AND DEPRECIATION AND AMORTISATION |
|
53.118 |
31.697 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
|
16.707 |
13.538 |
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE DEPRECIATION AND AMORTISATION
|
|
36.411 |
18.159 |
|
|
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION |
|
0.843 |
0.833 |
|
|
|
|
|
|
|
|
|
|
NET PROFIT |
|
35.568 |
17.326 |
|
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry Debtors / Income * 365 Days) |
|
117.31 |
109.22 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
|
3.11 |
3.34 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
|
122.89 |
98.49 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
|
0.35 |
0.36 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
|
11.84 |
6.70 |
LEVERAGE RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing + Current Liabilities) / Total Assets) |
|
0.83 |
0.83 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
|
1.04 |
1.15 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
|
4.42 |
4.60 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
|
0.04 |
0.06 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
|
3.18 |
2.34 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
|
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
|
(161.77) |
(54.03) |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
|
(365.05) |
(140.57) |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
|
(2157.33) |
(832.34) |
SOLVENCY RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current Assets / Current Liabilities) |
|
1.29 |
1.25 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
|
1.00 |
1.02 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
|
0.17 |
0.17 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
|
1.04 |
1.15 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
|
1.29 |
1.25 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
|
Partner Capital |
84.341 |
115.357 |
|
Reserves & Surplus |
0.000 |
0.000 |
|
Net
worth |
84.341 |
115.357 |
|
Secured Loans |
27.134 |
56.381 |
|
Unsecured Loans |
70.073 |
63.332 |
|
Total
borrowings |
97.207 |
119.713 |
|
Debt/Equity
ratio |
1.153 |
1.038 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
|
Sales |
1299.327 |
1538.358 |
|
|
|
18.397 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
|
|
(INR
In Million) |
(INR
In Million) |
|
Sales |
1299.327 |
1538.358 |
|
Profit |
17.326 |
35.568 |
|
|
1.33% |
2.31% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
Yes |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
No |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
No |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
Yes |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
Yes |
|
19 |
Major customers |
Yes |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
Yes |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last two years |
Yes |
|
30 |
Major shareholders, if available |
No |
|
31 |
External Agency Rating, if available |
Yes |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
Yes |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
UNSECURED LOANS
|
PARTICULARS |
31.03.2016 (INR
In Million) |
31.03.2015 (INR
In Million) |
|
From Relatives |
|
|
|
Bhavin M. Ajmera (Huf) |
4.200 |
3.669 |
|
Devang M. Ajmera (Huf) |
4.300 |
3.761 |
|
Jayana P. Ajmera |
2.900 |
2.050 |
|
Manharlal P. Ajmera |
0.622 |
0.430 |
|
Manharlal Pranlal Ajmera (Huf) |
2.553 |
1.946 |
|
Meenaben M. Ajmera |
1.600 |
1.133 |
|
Piyush M. Ajmera (Huf) |
4.325 |
3.413 |
|
Preeti D. Ajmera |
5.175 |
4.050 |
|
Siddhi B. Ajmera |
3.325 |
2.450 |
|
From Friends |
|
|
|
Ankit Laherchand Maisheri |
1.768 |
1.596 |
|
Ashok Bhabhutram Avasthi |
0.736 |
0.665 |
|
Deepak Sayla |
2.803 |
2.530 |
|
Manoj Hirchand Motta |
1.195 |
1.078 |
|
Nanji. K. Pasad (Huf) |
0.569 |
0.514 |
|
Navin N. Jain (Huf) |
3.680 |
2.000 |
|
Niral Z. Lodaya |
4.809 |
4.340 |
|
Prisha Enterprises |
0.500 |
0.500 |
|
Rishni M. Lakhani |
2.500 |
2.905 |
|
Tamudevi Daulatram Nag |
2.216 |
2.000 |
|
Tilakchand Jain |
1.489 |
0.000 |
|
Uday Baban Chavan |
0.228 |
0.205 |
|
Veena Z. Lodaya |
5.336 |
4.816 |
|
Vipul K. Dehia Huf |
0.340 |
0.307 |
|
Zaverchand K. Lodaya (Huf) |
5.340 |
4.820 |
|
Zaverchand Lodaya |
0.823 |
0.751 |
|
Ajmera Associates Limited |
0.000 |
7.500 |
|
Chetna Vijay Kumar |
0.000 |
1.000 |
|
Cosmos International |
0.000 |
0.400 |
|
Cosmos Pharmachem |
0.000 |
0.400 |
|
International Financial Service Limited |
0.000 |
7.500 |
|
Kasturbai Jain |
0.000 |
1.344 |
|
|
|
|
|
Total |
63.332 |
70.073 |
FIXED ASSETS:
Tangible Assets
·
Furniture
·
Mobile
·
Office Equipment
·
Machine
·
Printer
·
Air Conditioner Machine
·
Inverter
·
Accessories
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any
of its beneficial owners, controlling shareholders or senior officers as
terrorist or terrorist organization or whom notice had been received that all
financial transactions involving their assets have been blocked or convicted,
found guilty or against whom a judgement or order had been entered in a
proceedings for violating money-laundering, anti-corruption or bribery or
international economic or anti-terrorism sanction laws or whose assets were
seized, blocked, frozen or ordered forfeited for violation of money laundering
or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is or
was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the
property or assets of the subject are derived from criminal conduct or a
prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No
record exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our
market survey revealed that the amount of compensation sought by the subject is
fair and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 63.98 |
|
UK Pound |
1 |
INR 88.13 |
|
Euro |
1 |
INR 78.35 |
INFORMATION DETAILS
|
Information Gathered
by : |
SUP |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
IND |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with moderate
risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on secured
terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as
a reference to assess SC’s credit risk and to set the amount of credit to be
extended. It is calculated from a composite of weighted scores obtained from
each of the major sections of this report. The assessed factors are as follows:
·
Financial condition covering various ratios
·
Company background and operations size
·
Promoters / Management background
·
Payment record
·
Litigation against the subject
·
Industry scenario / competitor analysis
·
Supplier / Customer / Banker review (wherever
available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.